Reviewing Advanced Oxygen Technologies (OTCMKTS:AOXY) & Kennedy-Wilson (OTCMKTS:KW)

Advanced Oxygen Technologies (OTCMKTS:AOXY) and Kennedy-Wilson (NYSE:KW) are both finance companies, but which is the better business? We will compare the two businesses based on the strength of their earnings, analyst recommendations, dividends, institutional ownership, valuation, profitability and risk.

Valuation and Earnings

This table compares Advanced Oxygen Technologies and Kennedy-Wilson’s gross revenue, earnings per share (EPS) and valuation.

Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio
Advanced Oxygen Technologies $40,000.00 6.58 $10,000.00 N/A N/A
Kennedy-Wilson $773.50 million 4.15 $150.00 million N/A N/A

Kennedy-Wilson has higher revenue and earnings than Advanced Oxygen Technologies.

Volatility & Risk

Advanced Oxygen Technologies has a beta of -0.79, meaning that its share price is 179% less volatile than the S&P 500. Comparatively, Kennedy-Wilson has a beta of 1.11, meaning that its share price is 11% more volatile than the S&P 500.


Kennedy-Wilson pays an annual dividend of $0.84 per share and has a dividend yield of 3.7%. Advanced Oxygen Technologies does not pay a dividend.

Institutional & Insider Ownership

81.6% of Kennedy-Wilson shares are held by institutional investors. 0.2% of Advanced Oxygen Technologies shares are held by company insiders. Comparatively, 14.7% of Kennedy-Wilson shares are held by company insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a stock is poised for long-term growth.


This table compares Advanced Oxygen Technologies and Kennedy-Wilson’s net margins, return on equity and return on assets.

Net Margins Return on Equity Return on Assets
Advanced Oxygen Technologies 31.54% 4.21% 1.91%
Kennedy-Wilson 13.61% 13.49% 2.54%

Analyst Ratings

This is a summary of recent recommendations and price targets for Advanced Oxygen Technologies and Kennedy-Wilson, as provided by MarketBeat.

Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Advanced Oxygen Technologies 0 0 0 0 N/A
Kennedy-Wilson 0 0 3 0 3.00

Kennedy-Wilson has a consensus price target of $26.51, indicating a potential upside of 17.60%. Given Kennedy-Wilson’s higher possible upside, analysts plainly believe Kennedy-Wilson is more favorable than Advanced Oxygen Technologies.


Kennedy-Wilson beats Advanced Oxygen Technologies on 10 of the 12 factors compared between the two stocks.

Advanced Oxygen Technologies Company Profile

Advanced Oxygen Technologies, Inc., through its subsidiary, Anton Nielsen Vojens, ApS, owns and leases a commercial real estate property in Vojens, Denmark. Its property is land only, as well as a 750 square meters parcel that is used as a fuel station. The company was formerly known as Aquanautic Corporation. Advanced Oxygen Technologies, Inc. was incorporated in 1981 and is based in Randolph, Vermont.

Kennedy-Wilson Company Profile

Kennedy-Wilson Holdings, Inc. is a global real estate investment company, which engages in the ownership, operation, and investment in real estate through its investment platform. It operates through the following business segments: KW Investments, and KW Investment Management and Real Estate Services (IMRES). The KW Investments segment invests the capital of the company in real estate assets and loans secured by real estate either on its own or with strategic partners through publicly traded companies, joint ventures, separate accounts, and funds. The IMRES segment includes the investment management platform of the company along with its property services, research, brokerage and auction, and conventional sales divisions. The company was founded in 1977 and is headquartered in Beverly Hills, CA.

Receive News & Ratings for Advanced Oxygen Technologies Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Advanced Oxygen Technologies and related companies with's FREE daily email newsletter.